Abstract
| Lingua originale | English |
|---|---|
| Stato di pubblicazione | Published - 2012 |
Fingerprint
Cita questo
Adverse Events in Treatment of Inherited Factor VII Deficiency: Final Analysis of the STER. / Mariani, G; Dolce, A; Bertrand, M; Charoenkwan, P; Micic, D; Fernanda López, Mf; Ruiz De Saez, A; Ingerslev, J;.
2012.Risultato della ricerca: Paper
}
TY - CONF
T1 - Adverse Events in Treatment of Inherited Factor VII Deficiency: Final Analysis of the STER
AU - Mariani, G; Dolce, A; Bertrand, M; Charoenkwan, P; Micic, D; Fernanda López, Mf; Ruiz De Saez, A; Ingerslev, J;
AU - Siragusa, Sergio
AU - Napolitano, Mariasanta
PY - 2012
Y1 - 2012
N2 - No evidence-based guidelines are available for the treatment of Factor VII deficiency. Replacement therapy (RT) is still influenced by different factors as rarity of the disorder, availability and supply of products and economic reasons. All RTs are not exempt of side effects and scanty data is available about the safety of the products currently used. Aim of this study was to analyze adverse events (AEs) of RTs for congenital Factor VII deficiency, as reported in Seven Treatment Evaluation Registry (STER).
AB - No evidence-based guidelines are available for the treatment of Factor VII deficiency. Replacement therapy (RT) is still influenced by different factors as rarity of the disorder, availability and supply of products and economic reasons. All RTs are not exempt of side effects and scanty data is available about the safety of the products currently used. Aim of this study was to analyze adverse events (AEs) of RTs for congenital Factor VII deficiency, as reported in Seven Treatment Evaluation Registry (STER).
KW - Adverse Events, Inherited Fasctor VII deficiency
UR - http://hdl.handle.net/10447/76370
M3 - Paper
ER -